Article Text

Download PDFPDF
State of the art: multimodality imaging in dilated cardiomyopathy
  1. Brian P Halliday1,2
  1. 1CMR Unit and Inherited Cardiac Conditions Care Group, Royal Brompton and Harefield Hospitals, London, UK
  2. 2National Heart and Lung Institute, Imperial College London, London, UK
  1. Correspondence to Dr Brian P Halliday, CMR Unit and Inherited Cardiac Conditions Care Group, Royal Brompton and Harefield Hospitals, London, London, UK; b.halliday{at}rbht.nhs.uk

Abstract

Dilated cardiomyopathy represents a common phenotype expressed in individuals with a family of overlapping myocardial diseases due to acquired and/or genetic susceptibility. Disease trajectory, response to therapy and outcomes vary widely; therefore, further refinement of the diagnosis can help guide therapy and inform prognosis. Multimodality imaging plays a key role in this process, as well as excluding alternative causes which may mimic a primary myocardial disease. The following article discusses the role of different imaging modalities as well as what the future may look like in the context of recent research innovations.

  • Cardiomyopathy, Dilated
  • Cardiac Imaging Techniques

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Twitter @bp_halliday

  • Contributors BHP is the sole contributor to this article.

  • Funding BPH is supported by a British Heart Foundation Intermediate Fellowship (FS/ICRF/20/26019) and the Rosetrees Trust.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; externally peer reviewed.

  • Author note References which include a * are considered to be key references.